Victoria A. Brentville
University Park
Nottingham, ENG, United Kingdom
Nottingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Immunomodulator loaded microneedle arrays for targeted intradermal drug delivery to skin tumors.
Journal: Drug delivery
Published: July 10, 2025
In Vivo Evaluation of Pam2Cys-Modified Cancer-Testis Antigens as Potential Self-Adjuvanting Cancer Vaccines.
Journal: Journal of peptide science : an official publication of the European Peptide Society
Published: January 23, 2025
Sparsely PEGylated poly(beta-amino ester) polyplexes enhance antigen specific T-cell response of a bivalent SARS-CoV-2 DNA vaccine.
Journal: Biomaterials
Published: January 08, 2024
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors.
Journal: Cancer immunology, immunotherapy : CII
Published: January 03, 2024
Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: September 13, 2023
Combined biolistic and cell penetrating peptide delivery for the development of scalable intradermal DNA vaccines.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 26, 2023
Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy.
Journal: Frontiers in immunology
Published: October 10, 2022
Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool.
Journal: Immunology
Published: February 24, 2022
Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides via Multiple HLA-Types and Confer Anti-Tumor Immunity.
Journal: Frontiers in immunology
Published: February 11, 2022
PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.
PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: January 08, 2022
Last Updated: 09/26/2026